• 2010

Company Description

Anokion is harnessing the power of natural immune equilibrium to develop solutions for antigen-specific immune tolerance.

Anokion, a spin-off from the Ecole Polytechnique Fédérale de Lausanne (EPFL), is focused on applying the company’s antigen-specific immune tolerance technology to reduce the immunogenicity of therapeutic proteins and to treat autoimmune and allergic diseases. As a platform technology, Anokion’s approach to antigen-specific tolerance can be translated to virtually any protein in numerous clinical indications.

  • Manufacturer:

    Science and Engineering
  • Formed:

  • Founders:

    Melody Swartz
  • Company Website:

  • Company E-mail:

  • Company Address:

    EPFL Innovation Park, En Ruchoz ch. de la Dent d'Oche 1A
  • CEO:

    • Melody Swartz